单克隆抗体（癌抗原125）在卵巢癌连续监测中的价值：与循环免疫复合物的比较。

The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes.

作者信息

Dodd J, Tyler J P, Crandon A J, Blumenthal N J, Fay R A, Baird P J, Hicks L J, Hudson C N

出版信息

Br J Obstet Gynaecol. 1985 Oct;92(10):1054-60. doi: 10.1111/j.1471-0528.1985.tb03003.x.

DOI:10.1111/j.1471-0528.1985.tb03003.x

Abstract

The use of circulating immune complexes and a commercial monoclonal antibody to ovarian cancer (CA 125 kit) in monitoring progress in patients with ovarian cancer has been assessed. While changes in immune complexes were apparent in some patients with active progression of disease, the marked change in values and linear trend make the use of CA 125 a useful clinical marker.

摘要

已经评估了循环免疫复合物和一种用于卵巢癌的商业单克隆抗体（CA 125试剂盒）在监测卵巢癌患者病情进展中的应用。虽然在一些疾病活跃进展的患者中免疫复合物有明显变化，但CA 125值的显著变化和线性趋势使其成为一种有用的临床标志物。